Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
724.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 22.00 (3.034%)
Market Cap: £49.23m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Statement re possible acquisition

30 Dec 2015 07:00

RNS Number : 3726K
Silver Falcon PLC
30 December 2015
 

30 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

 

Proposed acquisition of Lime Holdings Limited ("Lime")

 

Silver Falcon plc (LSE:SILF), the listed special purpose acquisition company, refers to its announcement of 23 December 2015 and is pleased to advise that it has entered into a non-binding Memorandum of Understanding with the board and principal shareholder in Lime Holdings Limited ("Lime") regarding a possible acquisition of 100% of the share capital of Lime by way of a share for share exchange ("Transaction").

Lime is an Australian unlisted public company which operates in the financial technology sector. It has developed an innovative platform for the insurance industry which facilitates the automated delivery of insurance to end users.

Lime has recently relocated its headquarters to the UK and is developing commercial partnerships in the UK and on an international basis.

Whilst a general understanding on the terms of the Transaction has been reached, these terms are subject to due diligence, a fundraising, and re-listing of the enlarged group on the London Stock Exchange. Accordingly there is no certainty that it will be completed.

If the Transaction is completed, it will constitute a reverse takeover under the Listing Rules. As the Company is unable to provide full disclosure under Rule 5.6.15 of the Listing Rules, the Company has requested a continuation of the current suspension of trading in its shares.

Further announcements will be made in due course as the Transaction progresses.

 

For further information please contact:

Silver Falcon: Tim Le Druillenec (Company Secretary), 07874 762821

Media enquiries: Jennifer Renwick, jennifer.renwick@camarco.co.uk, 0203 757 4994

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTLBPTMBTTBAA
Date   Source Headline
14th May 20187:00 amRNSDevelopment Agreement
8th May 20187:00 amRNSResearch Collaboration with Rockefeller University
30th Apr 20184:23 pmRNSFinal Results
11th Apr 20185:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSDirectorate Change
14th Mar 201811:05 amRNSSecond Price Monitoring Extn
14th Mar 201811:00 amRNSPrice Monitoring Extension
13th Mar 20187:00 amRNSCollaboration with major US biotechnology company
6th Mar 20187:00 amRNSAdvisory Board Appointment
1st Mar 20187:00 amRNSAlign Research Initiation of Coverage
27th Feb 20184:40 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
26th Feb 20182:17 pmRNSStmnt re Share Price Movement
12th Feb 20187:00 amRNSDirector/PDMR Shareholding
7th Feb 20187:00 amRNSDirector/PDMR Shareholding
11th Jan 20187:00 amRNSHemogenyx Welcomes N.Y. Lt. Governor to its Labs
7th Dec 201712:16 pmRNSResult of AGM
7th Dec 20177:00 amRNSAGM Statement
20th Nov 20177:00 amRNSUniversity of Oxford Collaboration
15th Nov 20177:00 amRNSDirectorate Change
14th Nov 20177:00 amRNSNotice of AGM
13th Nov 20174:40 pmRNSSecond Price Monitoring Extn
13th Nov 20174:35 pmRNSPrice Monitoring Extension
13th Nov 20172:05 pmRNSSecond Price Monitoring Extn
13th Nov 20172:00 pmRNSPrice Monitoring Extension
13th Nov 201711:05 amRNSSecond Price Monitoring Extn
13th Nov 201711:00 amRNSPrice Monitoring Extension
13th Nov 20179:05 amRNSSecond Price Monitoring Extn
13th Nov 20179:00 amRNSPrice Monitoring Extension
13th Nov 20177:00 amRNSStatement re Press Comment
30th Oct 20177:00 amRNSLakePharma appointed for lead product development
11th Oct 20177:00 amRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
5th Oct 20178:01 amRNSCornell University update
5th Oct 20178:00 amRNSAdmission & First Day of Dealings
4th Oct 201711:16 amRNSResult of General Meeting
26th Sep 20177:00 amRNSInvestor presentations
25th Sep 20177:00 amRNSHalf-year Report
11th Sep 20177:00 amRNSProposed acquisition and Placing & Subscription
13th Apr 20173:30 pmRNSFinal Results
30th Sep 20162:00 pmRNSProposed acquisition of Lime Holdings Limited
5th Aug 20167:00 amRNSInterim Report for the period ended 30 June 2016
29th Jun 20167:00 amRNSResults of Annual General Meeting
1st Jun 20169:43 amRNSPosting of Annual Report & Accounts
28th Apr 20167:00 amRNSFinal Results for period ended 31 December 2015
18th Feb 201610:33 amRNSChange of Accounting Reference Date
30th Dec 20157:00 amRNSStatement re possible acquisition
23rd Dec 201512:48 pmRNSSuspension of trading
23rd Dec 201512:45 pmRNSSuspension
18th Dec 201511:07 amRNSAppointment of Financial Advisor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.